R Sauvan

792 total citations
28 papers, 565 citations indexed

About

R Sauvan is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Oncology. According to data from OpenAlex, R Sauvan has authored 28 papers receiving a total of 565 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 7 papers in Genetics and 5 papers in Oncology. Recurrent topics in R Sauvan's work include BRCA gene mutations in cancer (6 papers), Cancer Genomics and Diagnostics (3 papers) and Advanced Proteomics Techniques and Applications (2 papers). R Sauvan is often cited by papers focused on BRCA gene mutations in cancer (6 papers), Cancer Genomics and Diagnostics (3 papers) and Advanced Proteomics Techniques and Applications (2 papers). R Sauvan collaborates with scholars based in France, Tunisia and Belgium. R Sauvan's co-authors include Daniel Birnbaum, Patrice Viens, J. Pasquier, François Eisinger, I. Brenot-Rossi, Jocelyne Jacquemier, Anthony Gonçalvès, Bernard François Michel, Jean‐Philippe Peyrat and H. Sobol and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Oncogene and International Journal of Cancer.

In The Last Decade

R Sauvan

26 papers receiving 544 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R Sauvan France 8 204 144 107 103 74 28 565
Haim Biran Israel 15 260 1.3× 129 0.9× 70 0.7× 200 1.9× 25 0.3× 40 841
P Sedlaczek Poland 13 172 0.8× 40 0.3× 65 0.6× 133 1.3× 22 0.3× 25 486
Kathrine Woie Norway 16 199 1.0× 67 0.5× 123 1.1× 162 1.6× 24 0.3× 46 710
Malte Böhm Germany 16 492 2.4× 71 0.5× 191 1.8× 154 1.5× 8 0.1× 39 825
Sabita K. Murthy Canada 13 371 1.8× 196 1.4× 83 0.8× 61 0.6× 16 0.2× 25 585
Carl Wibom Sweden 14 280 1.4× 34 0.2× 176 1.6× 54 0.5× 29 0.4× 31 507
Charlotte Abson United Kingdom 8 139 0.7× 28 0.2× 71 0.7× 157 1.5× 11 0.1× 11 500
Eliza Wickham United States 6 624 3.1× 99 0.7× 105 1.0× 59 0.6× 9 0.1× 6 786
Reet Rein Estonia 11 280 1.4× 127 0.9× 28 0.3× 70 0.7× 5 0.1× 17 636
Brian I. Lord United Kingdom 18 149 0.7× 94 0.7× 42 0.4× 205 2.0× 6 0.1× 34 655

Countries citing papers authored by R Sauvan

Since Specialization
Citations

This map shows the geographic impact of R Sauvan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Sauvan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Sauvan more than expected).

Fields of papers citing papers by R Sauvan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Sauvan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Sauvan. The network helps show where R Sauvan may publish in the future.

Co-authorship network of co-authors of R Sauvan

This figure shows the co-authorship network connecting the top 25 collaborators of R Sauvan. A scholar is included among the top collaborators of R Sauvan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Sauvan. R Sauvan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bourdon, Violaine, Laëtitia Huiart, François Eisinger, et al.. (2009). Molecular study of CEPBA in familial hematological malignancies. Familial Cancer. 8(4). 581–584. 4 indexed citations
2.
Monville, Florence, Sarah Garrido‐Urbani, Carole Berruyer-Pouyet, et al.. (2007). Nectin-4 is a new histological and serological tumor associated marker for breast cancer. BMC Cancer. 7(1). 73–73. 146 indexed citations
3.
Gonçalvès, Anthony, François Bertucci, R Sauvan, et al.. (2005). Postoperative serum proteomic profiles may predict metastatic relapse in high-risk primary breast cancer patients receiving adjuvant chemotherapy. Oncogene. 25(7). 981–989. 102 indexed citations
4.
Gonçalvès, Anthony, Benjamin Esterni, François Bertucci, et al.. (2005). Postoperative serum proteomic profiles and identification of biomarkers with prognosis value in high-risk early breast cancer patients. Breast Cancer Research. 7(S2). 2 indexed citations
5.
Degos, R, et al.. (2004). [Mast cell reticulosis].. PubMed. 58(4). 435–40. 1 indexed citations
6.
Sobol, Hagay, Norbert Vey, R Sauvan, et al.. (2002). Re: Familial multiple myeloma: A family study and review of the literature (multiple letters). JNCI Journal of the National Cancer Institute. 94(6). 461–463. 8 indexed citations
7.
Pasquier, J., et al.. (2002). Value of 99mTc-ECD SPET for the diagnosis of dementia with Lewy bodies. European Journal of Nuclear Medicine and Molecular Imaging. 29(10). 1342–1348. 78 indexed citations
8.
Sauvan, R, Tetsuro Noguchi, Daniel Serin, et al.. (2001). Three novel BRCA1 germline mutations (1104delAA, 1276delTT, 3747delGA) detected in breast/ovarian cancer families identified in the south of France. Human Mutation. 17(2). 154–154. 2 indexed citations
9.
10.
Brenot-Rossi, I., Réda Bouabdallah, V J Bardou, et al.. (2001). Hodgkin's disease: prognostic role of gallium scintigraphy after chemotherapy. European Journal of Nuclear Medicine and Molecular Imaging. 28(10). 1482–1488. 12 indexed citations
11.
Sauvan, R, et al.. (2000). [Treatment of permanent slow or paroxysmal pulse & auriculoventricular conduction disorders by sodium lactate].. PubMed. 73(22-24). 737–53.
12.
Eisinger, François, Jean‐Philippe Peyrat, Tetsuro Noguchi, et al.. (1999). Novel indications forBRCA1 screening using individual clinical and morphological features. International Journal of Cancer. 84(3). 263–267. 39 indexed citations
13.
Sobol, H., François Eisinger, R Sauvan, et al.. (1998). [Impact of recent oncogenetic progress on the management of high risk breast cancer patients: the example of BRCA1 and BRCA2 genes].. PubMed. 59(6). 459–64. 1 indexed citations
14.
Eisinger, François, J. Jacquemier, Colette Charpin, et al.. (1998). Mutations at BRCA1: the medullary breast carcinoma revisited.. PubMed. 58(8). 1588–92. 108 indexed citations
15.
Viallat, J. R., R Sauvan, F. Rey, C Boutin, & J. Pasquier. (1996). Contribution de deux biomarqueurs des cytokératines, le Cyfra 21-1 et le TPA, au diagnostic de mésothéliome pleural malin. Immuno-analyse & Biologie Spécialisée. 11(6). 372–378. 1 indexed citations
16.
Monges, G., Philippe Biagini, Jean‐François Cantaloube, et al.. (1993). Detection of gastrin mRNA in fresh human colonic carcinomas by reverse transcription-polymerase chain reaction. Journal of Molecular Endocrinology. 11(2). 223–229. 7 indexed citations
17.
Vialettes, B., Patrice Viens, Anne‐Marie Stoppa, et al.. (1993). Incidence rate and risk factors for thyroid dysfunction during recombinant interleukin-2 therapy in advanced malignancies. European Journal of Endocrinology. 129(1). 31–38. 25 indexed citations
18.
Sauvan, R, et al.. (1988). Systematic Association of PAP and PSA Determinations to Bone Scintigraphy in Prostatic Cancer. American Journal of Clinical Oncology. 11. S68–70. 5 indexed citations
19.
Sauvan, R, et al.. (1980). Clinical merits in the radioimmunoassay of free serum tetraiodothyronine (FT4) and free serum triiodothyronine (FT3). International Journal of Nuclear Medicine and Biology. 7(4). 386–390. 2 indexed citations
20.
Durand, Madéleine, et al.. (1960). [Phonocardiography of congenital heart diseases. I. Pulmonary stenosis].. PubMed. 53. 61–76. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026